We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Automated Inpatient Endocrinology Consultation for Osteoporotic Hip Fracture

This study has been terminated.
(Dr. Grose has left this practice, this study is terminated)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00643175
First Posted: March 26, 2008
Last Update Posted: December 30, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
State University of New York - Upstate Medical University
  Purpose
Osteoporosis has been called a "silent epidemic" whose prevalence is increasing. It often presents as a fragility fracture, with hospitalizations resulting from minimally traumatic hip fractures. While the fractures are treated appropriately, the underlying pathology is often ignored. Numerous studies have shown that prior fracture increases the risk for further fracture. In 2004 the Surgeon General released a report on osteoporosis, the details of which include multi-disciplinary treatment of osteoporotic fractures. Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Possible planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.

Condition Intervention
Osteoporosis Behavioral: Automated follow up

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by State University of New York - Upstate Medical University:

Estimated Enrollment: 20
Study Start Date: June 2007
Study Completion Date: January 2009
Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Osteoporosis in patients with fragility hip fractures.
Behavioral: Automated follow up
Treatment of osteoporosis after hip fracture is also being targeted as a future hospital quality assessment measure. Hospitals which have no plan in place to address osteoporosis treatment after hip fracture may be cited, and may have medicare money withheld. The goal of the study is to create an automated in-patient endocrinology consultation for osteoporotic hip fractures. We plan to gather patient data in a prospective manner including the endocrinologist recommendations, adherence to medical therapy after discharge, and future fracture rates. Planned interventions include only appropriate medical therapy for osteoporosis, DEXA bone scanning, and regularly scheduled telephone follow-up.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Using the existing WebCAIS order system, an automated endocrinology consult and appropriate laboratory studies will be drawn on all non-traumatic hip fractures. Data from these patients will be collected in a prospective study, and the patients will be followed up over time to check adherence to osteoporotic medical therapy and future incidence of re-fracture.
Criteria

Inclusion:

  1. over 55
  2. non-traumatic hip fracture

Exclusion criteria:

  1. currently on anti-osteoporosis pharmacotherapy including bisphosphonates, PTH, and calcitonin
  2. high energy nature of fracture, including MVA, fall from height greater than 3 feet
  3. severe dementia, lack of capacity
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00643175


Locations
United States, New York
SUNY Upstate Medical University
Syracuse, New York, United States, 13202
Sponsors and Collaborators
State University of New York - Upstate Medical University
  More Information

Responsible Party: Andrew Grose, MD, SUNY Upstate Medical University
ClinicalTrials.gov Identifier: NCT00643175     History of Changes
Other Study ID Numbers: osteoporotic hip fracture
First Submitted: March 24, 2008
First Posted: March 26, 2008
Last Update Posted: December 30, 2009
Last Verified: December 2009

Keywords provided by State University of New York - Upstate Medical University:
The main objective is to have an endocrinologist treat osteoporosis in patients with fragility hip fractures.

Additional relevant MeSH terms:
Osteoporosis
Hip Fractures
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases
Femoral Fractures
Fractures, Bone
Wounds and Injuries
Hip Injuries
Leg Injuries